000			01633nam a2200313Ia 4500
001			000008066
003			MX-MdCICY
005			20260113141736.0
008			120611s2012 fluaf f p 001 0 eng d
020			_a1439803234 (hardback : alk. paper)
020			_a9781439803233 (hardback : alk. paper)
040			_cCICY
082	0	4	_a610.28 _bS8 2012
245	1	0	_aStem cells and revascularization therapies / _cedited by Hyunjoon Kong, Andrew J. Putnam, Lawrence B. Schook
264	3	1	_aBoca Raton, FL : _bCRC Press, _cc2012
300			_axiii, 296 p., [32] p. de láminas : _bil. (algunas col.) ; _c25 cm.
504			_aincluye referencias bibliográficas e índice
520	3		_aIn the last few decades, significant advancements in the biology and engineering of stem cells have enabled progress in their clinical application to revascularization therapies. Some strategies involve the mobilization of endogenous stem cell populations, and others employ cell transplantation. However, both techniques have benefited from multidisciplinary efforts to créate biomaterials and other biomedical tools that can improve and control the fate of stem cells, and advance our understanding of them.
650	1	4	_aCELULAS MADRE
650	1	4	_aCELULAS MADRE _xTRANSPLANTE
650	1	4	_aINGENIERIA DE TEJIDOS
650	1	4	_aNEOVASCULARIZACION _xPSICOLOGIA
650	1	4	_aNEOVASCULARIZATION
700	1	2	_aKong, Hyunjoon, _eed.
700	1	2	_aPutnam, Andrew J., _eed.
700	1	2	_aSchook, Lawrence B., _eed.
856	4	0	_uhttps://www.cicy.mx/sitios/sib/doctoelectronico/8066.pdf _zVer tabla de contenido y/o resumen
942			_2ddc _cBK
999			_c7376 _d7376